-
公开(公告)号:BG104022A
公开(公告)日:2001-04-30
申请号:BG10402299
申请日:1999-12-16
Applicant: BASF AG
Inventor: AMBERG WILHELM , KLING ANDREAS , KLINGE DAGMAR , RIECHERS HARTMUT , HERGENRODER STEFAN , RASCHACK MANFRED , UNGER LILIANE
IPC: C07D251/16 , A61K31/4965 , A61K31/50 , A61K31/505 , A61K31/517 , A61K31/519 , A61K31/53 , A61P7/02 , A61P9/02 , A61P9/04 , A61P9/10 , A61P9/12 , A61P11/06 , A61P13/08 , A61P13/12 , A61P25/06 , A61P35/00 , A61P35/04 , A61P43/00 , C07C247/12 , C07D213/68 , C07D237/14 , C07D237/16 , C07D239/34 , C07D239/52 , C07D239/56 , C07D239/60 , C07D239/70 , C07D239/80 , C07D239/95 , C07D241/18 , C07D251/22 , C07D251/34 , C07D251/52 , C07D253/06 , C07D403/12 , C07D491/048 , C07C235/12 , C07C233/63 , C07C229/22 , C07C233/47 , C07C235/34
Abstract: The invention relates to carboxylic acid derivatives of formula wherein the constituents have the meaning given in the description. The invention also relates to the production of said derivatives, and to their use as endothelin receptor antagonists. 10 claims
-
公开(公告)号:PT862550E
公开(公告)日:2001-03-30
申请号:PT96930125
申请日:1996-08-29
Applicant: BASF AG
Inventor: UNGER LILIANE , AMBERG WILHELM , KLING ANDREAS , KLINGE DAGMAR , RIECHERS HARTMUT , RASCHACK MANFRED , HERGENRODER STEFAN , ELGER BERND , SCHULT SABINE
IPC: A61K31/00 , A61K31/19 , A61K31/192 , A61K31/34 , A61K31/341 , A61K31/343 , A61K31/35 , C07D317/02 , A61K31/352 , A61K31/357 , A61K31/36 , A61K31/435 , A61K31/44 , A61K31/505 , A61P9/00 , A61P9/08 , C07C53/134 , C07C57/30 , C07C57/32 , C07C57/38 , C07C59/64 , C07C69/616 , C07C69/734 , C07C255/00 , C07D213/55 , C07D213/64 , C07D221/04 , C07D239/26 , C07D239/34 , C07D239/52 , C07D239/70 , C07D257/04 , C07D307/79 , C07D317/50 , C07D317/60 , C07D319/02 , C07D319/18
Abstract: PCT No. PCT/EP96/03793 Sec. 371 Date Feb. 24, 1998 Sec. 102(e) Date Feb. 24, 1998 PCT Filed Aug. 29, 1996 PCT Pub. No. WO97/09294 PCT Pub. Date Mar. 13, 1997Carboxylic acid derivatives of the formula I here R1 is a tetrazole [sic], nitrile [sic], a group COOH or a radical which can be hydrolyzed to COOH, and the other substituents have the meaning explained in the description.
-
公开(公告)号:SI0862550T1
公开(公告)日:2001-02-28
申请号:SI9630188
申请日:1996-08-29
Applicant: BASF AG
Inventor: AMBERG WILHELM , KLING ANDREAS , KLINGE DAGMAR , RIECHERS HARTMUT , UNGER LILIANE , RASCHACK MANFRED , HERGENROEDER STEFAN , ELGER BERND , SCHULT SABINE
IPC: A61K31/00 , A61K31/19 , A61K31/192 , A61K31/34 , A61K31/341 , A61K31/343 , C07D317/02 , A61K31/35 , A61K31/352 , A61K31/357 , A61K31/36 , A61K31/435 , A61K31/44 , A61K31/505 , A61P9/00 , A61P9/08 , C07C53/134 , C07C57/30 , C07C57/32 , C07C57/38 , C07C59/64 , C07C69/616 , C07C69/734 , C07C255/00 , C07D213/55 , C07D213/64 , C07D221/04 , C07D239/26 , C07D239/34 , C07D239/52 , C07D239/70 , C07D257/04 , C07D307/79 , C07D317/50 , C07D317/60 , C07D319/02 , C07D319/18
Abstract: PCT No. PCT/EP96/03793 Sec. 371 Date Feb. 24, 1998 Sec. 102(e) Date Feb. 24, 1998 PCT Filed Aug. 29, 1996 PCT Pub. No. WO97/09294 PCT Pub. Date Mar. 13, 1997Carboxylic acid derivatives of the formula I here R1 is a tetrazole [sic], nitrile [sic], a group COOH or a radical which can be hydrolyzed to COOH, and the other substituents have the meaning explained in the description.
-
公开(公告)号:GR3034797T3
公开(公告)日:2001-02-28
申请号:GR20000402475
申请日:2000-11-09
Applicant: BASF AG
Inventor: AMBERG WILHELM , KLING ANDREAS , KLINGE DAGMAR , RIECHERS HARTMUT , UNGER LILIANE , RASCHACK MANFRED , HERGENROEDER STEFAN , ELGER BERND , SCHULT SABINE
IPC: A61K31/00 , A61K31/19 , A61K31/192 , A61K31/34 , A61K31/341 , A61K31/343 , C07D317/02 , A61K31/35 , A61K31/352 , A61K31/357 , A61K31/36 , A61K31/435 , A61K31/44 , A61K31/505 , A61P9/00 , A61P9/08 , C07C53/134 , C07C57/30 , C07C57/32 , C07C57/38 , C07C59/64 , C07C69/616 , C07C69/734 , C07C255/00 , C07D213/55 , C07D213/64 , C07D221/04 , C07D239/26 , C07D239/34 , C07D239/52 , C07D239/70 , C07D257/04 , C07D307/79 , C07D317/50 , C07D317/60 , C07D319/02 , C07D319/18
Abstract: PCT No. PCT/EP96/03793 Sec. 371 Date Feb. 24, 1998 Sec. 102(e) Date Feb. 24, 1998 PCT Filed Aug. 29, 1996 PCT Pub. No. WO97/09294 PCT Pub. Date Mar. 13, 1997Carboxylic acid derivatives of the formula I here R1 is a tetrazole [sic], nitrile [sic], a group COOH or a radical which can be hydrolyzed to COOH, and the other substituents have the meaning explained in the description.
-
公开(公告)号:PL340756A1
公开(公告)日:2001-02-26
申请号:PL34075698
申请日:1998-11-04
Applicant: BASF AG
Inventor: AMBERG WILHELM , JANSEN ROLF , HILLEN HEINZ , HERGENROEDER STEFAN , RASCHACK MANFRED , UNGER LILIANE
IPC: C07D249/12 , A61K31/41 , A61K31/415 , A61K31/4164 , A61K31/42 , A61K31/421 , A61K31/422 , A61K31/4245 , A61K31/425 , A61K31/426 , A61K31/427 , A61K31/428 , A61K31/433 , A61P9/04 , A61P9/08 , A61P9/10 , A61P9/12 , A61P11/06 , A61P13/08 , A61P13/12 , A61P35/00 , A61P43/00 , C07D231/20 , C07D233/70 , C07D261/12 , C07D263/38 , C07D271/06 , C07D271/10 , C07D273/01 , C07D275/02 , C07D275/03 , C07D277/20 , C07D277/32 , C07D277/34 , C07D277/60 , C07D277/68 , C07D285/00 , C07D285/08 , C07D285/12 , C07D291/04 , C07D413/12 , C07D417/12
Abstract: The present invention relates to carboxylic acid derivatives of the formula Ithe substituents having the meanings explained in the description, preparation and use as endothelin receptor antagonists.
-
公开(公告)号:ES2153124T3
公开(公告)日:2001-02-16
申请号:ES96930125
申请日:1996-08-29
Applicant: BASF AG
Inventor: AMBERG WILHELM , KLING ANDREAS , KLINGE DAGMAR , RIECHERS HARTMUT , UNGER LILIANE , RASCHACK MANFRED
IPC: A61K31/00 , A61K31/19 , A61K31/192 , A61K31/34 , A61K31/341 , A61K31/343 , A61K31/35 , C07D317/02 , A61K31/352 , A61K31/357 , A61K31/36 , A61K31/435 , A61K31/44 , A61K31/505 , A61P9/00 , A61P9/08 , C07C53/134 , C07C57/30 , C07C57/32 , C07C57/38 , C07C59/64 , C07C69/616 , C07C69/734 , C07C255/00 , C07D213/55 , C07D213/64 , C07D221/04 , C07D239/26 , C07D239/34 , C07D239/52 , C07D239/70 , C07D257/04 , C07D307/79 , C07D317/50 , C07D317/60 , C07D319/02 , C07D319/18
Abstract: PCT No. PCT/EP96/03793 Sec. 371 Date Feb. 24, 1998 Sec. 102(e) Date Feb. 24, 1998 PCT Filed Aug. 29, 1996 PCT Pub. No. WO97/09294 PCT Pub. Date Mar. 13, 1997Carboxylic acid derivatives of the formula I here R1 is a tetrazole [sic], nitrile [sic], a group COOH or a radical which can be hydrolyzed to COOH, and the other substituents have the meaning explained in the description.
-
公开(公告)号:NO20010622D0
公开(公告)日:2001-02-06
申请号:NO20010622
申请日:2001-02-06
Applicant: BASF AG
Inventor: AMBERG WILHELM , JANSEN ROLF , KETTSCHAU GEORG , HERGENROEDER STEFAN , RASCHACK MANFRED , UNGER LILIANE
IPC: C07D251/22 , A61K31/505 , A61K31/517 , A61K31/519 , A61K31/53 , A61K45/00 , A61P9/04 , A61P9/10 , A61P9/12 , A61P13/08 , A61P13/12 , A61P35/00 , A61P43/00 , C07D239/34 , C07D239/52 , C07D239/60 , C07D239/70 , C07D251/52 , C07D401/12 , C07D403/12 , C07D405/12 , C07D491/048 , C07D495/04 , C07D
Abstract: The invention relates to new carboxylic acid derivatives of the formula (I), where the substituents have the meaning given in the description, their production and their use as endothelin-receptor antagonists.
-
公开(公告)号:BG103258A
公开(公告)日:2000-12-29
申请号:BG10325899
申请日:1999-03-16
Applicant: BASF AG
Inventor: AMBERG WILHELM , JANSEN ROLF , KLING ANDREAS , KLINGE DAGMAR , RIECHERS HARTMUT , HERGENRODER STEFAN , RASCHACK MANFRED , UNGER LILIANE
IPC: A61K31/505 , A61K31/506 , A61K31/519 , A61P9/04 , A61P9/08 , A61P9/12 , A61P43/00 , C07C59/66 , C07C69/734 , C07D239/34 , C07D239/52 , C07D239/60 , C07D239/70 , C07D491/04 , C07D491/048
Abstract: The derivatives of carboxylic acids have the formula where R1 means tetrazole or the group (a); R2 means hydrogen, hydroxy, amino, NH(C1-C4-alkyl), N(C1-C4-alkyl)2; halogen, C1-C4 alkyl, C2-C4 alkenyl, C1-C4 halogenalkyl, C1-C4 alkoxy, C1-C4 halogenalkoxy or C1-C4 alkylthio, or CR2 together with CR10, as shown below, form 5- or 6-member ring, N is nitrogen or methine, Y is nitrogen or methine. Z is nitrogen or CR10, where R10 is hydrogen or C1-C4 alkyl or CR10 together with CR2 or with CR3 form 5- or 6-member alkylene or alkenyl ring where one or more methylene groups can be substituted with oxygen, sulphur, -NH or -N(C1-C4-alkyl), R3 is hydrogen, hydroxy, amino, NH(C1-C4-alkyl), N(C1-C4-alkyl), N(C1-C4-alkyl)2, halogen, C1-C4 alkyl, C2-C4 alkenyl, C2-C4 alkynyl, C1-C4 hydroxyalkyl, C1-C4 halogenalkyl, C1-C4 alkoxy, C1-C4 halogenalkoxy, C1-C4 alkylthio or CR3 together with CR10, as indicated above, form 5- or 6-member ring, R4 & R5 (which can be the same or different) are phenyl, optionally substituted, or phenyl or naphthyl which are interconnected in orthoposition by a direct bond, by methylene, ethylene or ethenyl group, with oxygen or sulphur or by the group SO2-, NH- or N-alkyl, C3-C8-cycloalkyl, optionally substituted, R6 is C3-C8 cycloalkyl, optionally substituted, phenyl or naphthyl, optionally substituted, or 5- or 6-member heteroaromatic ring containing from one to three nitrogen atoms and/or one sulphur or oxygen atom, W is sulphur or oxygen, Q is a dividing group which by length corresponds to a C2-C4 chain. The invention also relates to physiologically acceptable salts of these compounds, as well as to their pure enantiomer or diastereomer forms, to their preparation and application as mixed ETA/ETB-receptor antagonists. 10 claims
-
公开(公告)号:CZ20003219A3
公开(公告)日:2000-12-13
申请号:CZ20003219
申请日:1999-02-25
Applicant: BASF AG
Inventor: AMBERG WILHELM , JANSEN ROLF , KLINGE DAGMAR , RIECHERS HARTMUT , HERGENROEDER STEFAN , RASCHACK MANFRED , UNGER LILIANE
IPC: A61K31/505 , A61P9/00 , C07D213/64 , C07D239/34 , C07D239/52 , C07D251/22 , C07D403/12
-
公开(公告)号:SK4592000A3
公开(公告)日:2000-12-11
申请号:SK4592000
申请日:1998-10-16
Applicant: BASF AG
Inventor: AMBERG WILHELM , JANSEN ROLF , HERGENRODER STEFAN , RASCHACK MANFRED , UNGER LILIANE
IPC: A61K31/505 , A61K31/506 , A61K31/517 , A61K31/519 , A61K31/5377 , A61P9/02 , A61P9/10 , A61P9/12 , A61P13/08 , A61P13/12 , A61P35/00 , A61P43/00 , C07D239/34 , C07D239/36 , C07D239/52 , C07D239/60 , C07D239/70 , C07D401/12 , C07D403/12 , C07D491/048
Abstract: The invention relates to carboxylic acid derivatives of formula (I), wherein the substituents have the meaning as commented in the description. It also relates to the production and use of same as endothelin receptor antagonists.
-
-
-
-
-
-
-
-
-